Vienna, Austria, and Rijswijk, The Netherlands – Lexogen, a transcriptomics and next-generation sequencing company and Bluebee, a global bioinformatics platform, have announced today the implementation of QuantSeq Unique Molecular Identifiers (UMI) data analysis pipeline on the Bluebee genomics analysis platform. This collaboration offers QuantSeq users utilizing UMIs the opportunity to analyze samples in a convenient and rapid manner […]

Oxford, UK. Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its SureSeq myPanel™ NGS Custom Cancer Panel content – now covering 120 fully optimised cancer related genes. The expanded content gives researchers even more freedom to customise their sequencing experiments, enabling focus on regions of interest, saving time and cost. As well as proactive updates, this expansion […]

New publication maps ligase fidelity profiles with single molecule real-time sequencing to enable 20+ fragment assemblies with high efficiency and accuracy IPSWICH, MA, USA — Some of today’s most exciting molecular biology engineering — including the creation of customized CRISPR/Cas9 and TALEN constructs for genome editing — are led by synthetic biologists. These scientists are […]

NGS-based microbiome profiling delivers enhanced insights for metagenomics studies Gut bacteria play an important role in human health, as changes in the microbiome can be potentially harmful, and may be associated with chronic conditions such as inflammatory bowel disease, obesity and cancer.* Next-generation sequencing (NGS) technologies can deliver the necessary details to characterize microbial communities, […]

Joint offering enables acceleration of genomic panel design for translational and clinical disease research SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation announced today that it has entered into a co-marketing agreement with Genomenon to offer evidence-based genomic panel design services for translational and clinical disease research. The rapidly expanding knowledge base of genes and variants associated with […]

MENLO PARK, Calif. — Pacific Biosciences of California Inc., (Nasdaq:PACB) today announced that obtaining microbial genomes with high accuracy and contiguity has become faster and more affordable thanks to new multiplexing tools it will feature at the upcoming American Society for Microbiology (ASM) annual meeting in Atlanta. The increased throughput of the PacBio® Sequel® System enables multiple microbes to be sequenced […]

Zymo Research and CosmosID announce their partnership to provide microbiome researchers with an integrated end to end solution for accurate microbiome analysis.   The partnership combines Zymo Research’s complete microbiomics product portfolio from sample collection/preservation, mock microbial community standards, nucleic acid isolation, and library preparation with the largest curated microbiome database maintained and powered by CosmosID. The combined technologies of […]

Gonorrhoea, Deadly Plague and Dysentery Among Collection of Bacterial Genomes Now Publicly Available Through Collaboration with Pacific Biosciences HINXTON, United Kingdom and MENLO PARK, Calif. — The genomes of more than 3,000 bacteria, including some of the world’s most dangerous, have been sequenced by researchers at the Wellcome Sanger Institute in collaboration with Pacific Biosciences (PacBio). Infecting tens of millions of […]

Engineered Cells single-click ordering and knockout guarantee removes barriers to world-class CRISPR results REDWOOD CITY, California — Synthego, the leading genome engineering solutions company, launches its Engineered Cells Portfolio with immediate access to Knockout Clone & Pool, and Advanced Cells. The Knockout Clone and Pool products enable single-click online ordering of any human cell line with […]

FUJIFILM Cellular Dynamics, Inc., licenses University of California – Irvine’s technologies for derivation of microglia MADISON, Wis. — FUJIFILM Cellular Dynamics, Inc. (FCDI), a leading developer and manufacturer of human induced pluripotent stem cells (iPSCs) and differentiated tissue-specific iPSCs, announced today that it has entered into an exclusive patent license agreement with the University of California – Irvine (UCI) through its […]